Disc Medicine, Inc. Stock Analysis & AI Score
Disc Medicine, Inc. (IRON) has an ST Score of 43.3 (C), driven by its Forecast (B+) and held back by its Sentiment (F). Analysts rate it Buy with a $106.00 price target (+59.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Disc Medicine, Inc. (IRON) has an ST Score of 43.3 (C), driven by its Forecast (B+) and held back by its Sentiment (F). Analysts rate it Buy with a $106.00 price target (+59.5% upside).
- Strongest
- ForecastB+
- Weakest
- SentimentF
All factor grades
- ForecastB+
- Financial StrengthB
- ValuationB-
- ProfitabilityB-
- MomentumB-
- GrowthC-
- SentimentF
- Piotroski1/9
Contact
IRON stock: frequently asked questions
What is IRON's ST Score?
Disc Medicine, Inc. (IRON) has an ST Score of 43.3 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is IRON a buy, hold, or sell?
Analysts rate IRON a Buy, with a price target of $106.00 (+59.5% vs the current price). Our ST Score grades it C (43.3/100). The ST Score is a data-driven signal, not a recommendation.
What are IRON's factor grades?
Valuation B-, Profitability B-, Financial Strength B, Momentum B-, Growth C-, Forecast B+, Sentiment F.
What is IRON's valuation grade?
Disc Medicine, Inc. (IRON) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is IRON's growth grade?
Disc Medicine, Inc. (IRON) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is IRON's profitability grade?
Disc Medicine, Inc. (IRON) earns a profitability grade of B-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is IRON's financial strength grade?
Disc Medicine, Inc. (IRON) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for IRON?
The average analyst price target for Disc Medicine, Inc. (IRON) is $106.00 from 11 analysts, which is +59.5% versus the recent price of $66.44.
What is IRON's Piotroski score?
Disc Medicine, Inc. (IRON) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.